Gainers
- DBV Technologies DBVT shares moved upwards by 38.81% to $1.99 during Monday's regular session. As of 12:33 EST, this security is trading at a volume of 56.7 million shares, making up 9602.37% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $217.8 million.
- Tricida TCDA shares moved upwards by 15.52% to $6.5. Trading volume for Tricida's stock is 2.4 million as of 12:33 EST. This is 215.19% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $324.8 million.
- Acorda Therapeutics ACOR stock rose 15.51% to $1.01. Trading volume for this security as of 12:33 EST is 3.0 million, which is 54.49% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $48.4 million.
- Erytech Pharma ERYP stock increased by 14.34% to $5.74. Erytech Pharma's stock is trading at a volume of 131 shares as of 12:33 EST. This is 2.94% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $102.9 million.
- BioLine Rx BLRX shares rose 14.04% to $2.26. The current volume of 10.1 million shares is 293.89% of BioLine Rx's average full-day volume over the last 100 days (last updated at 12:33 EST). The market value of their outstanding shares is at $44.6 million.
- ProPhase Labs PRPH stock moved upwards by 13.95% to $8.25. The current volume of 154.6K shares is 52.12% of ProPhase Labs's average full-day volume over the last 100 days (last updated at 12:33 EST). The company's market cap stands at $95.6 million.
Losers
- Liquidia Technologies LQDA stock fell 28.58% to $3.3 during Monday's regular session. The current volume of 3.6 million shares is 600.43% of Liquidia Technologies's average full-day volume over the last 100 days (last updated at 12:33 EST). The market value of their outstanding shares is at $93.6 million.
- Titan Pharmaceuticals TTNP shares fell 22.39% to $0.11. Trading volume for Titan Pharmaceuticals's stock is 105.7 million as of 12:33 EST. This is 1080.21% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $10.4 million.
- Jounce Therapeutics JNCE stock declined by 16.71% to $6.93. As of 12:33 EST, this security is trading at a volume of 1.1 million shares, making up 94.37% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $235.9 million.
- Equillium EQ shares fell 14.49% to $5.43. Trading volume for this security as of 12:33 EST is 1.0 million, which is 137.93% of its average full-day volume over the last 100 days. The company's market cap stands at $96.0 million.
- Rexahn Pharmaceuticals REXN shares declined by 14.3% to $1.84. Trading volume for this security as of 12:33 EST is 289.7K, which is 502.39% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $7.4 million.
- Keros Therapeutics KROS stock decreased by 11.43% to $49.25. Keros Therapeutics's stock is trading at a volume of 203.5K shares as of 12:33 EST. This is 183.09% of its average full-day volume over the last 100 days. The company's market cap stands at $992.3 million.
Market News and Data brought to you by Benzinga APIs
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in